MedTrace Logo

Cryoablation vs Thoracoscopic Surgery for GGN

NCT06848881 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-03-20

No results posted yet for this study

Summary

The aim of this study is to investigate the efficacy and safety of Cryoablation and Thoracoscopic Surgery in the treatment of pulmonary ground-glass nodules.

Conditions

  • Ground-Glass Opacity

Interventions

PROCEDURE

Cryoablation

The eligible patient will be voluntarily assigned to the cryoablation group and receive cryoablation.

PROCEDURE

Thoracoscopic Surgery

The eligible patient will be voluntarily assigned to thoracoscopic surgery group and receive surgery.

Sponsors & Collaborators

  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Jiayuan Sun, MD, PhD · Shanghai Chest Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-20
Primary Completion
2030-04-15
Completion
2030-04-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06848881 on ClinicalTrials.gov